Does Xyrem Influence Brain Dopamine in Patients With Narcolepsy? A PET Imaging Investigation

Trial Profile

Does Xyrem Influence Brain Dopamine in Patients With Narcolepsy? A PET Imaging Investigation

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Sodium oxybate (Primary)
  • Indications Cataplexy; Narcolepsy
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Nov 2017 Planned number of patients changed from 15 to 30.
    • 08 Jan 2016 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
    • 24 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top